Insulin immunoassays in the detection of insulin analogues in factitious hypoglycemia

Endocrine Practice

Volumn 14, Issue 8, 2008, Pages 1006-1010

  Neal, J Matthew ^a   Han, Wen ^a  

^a BALL MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTAME; C PEPTIDE; GLUCOSE; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; PROINSULIN; DRUG DERIVATIVE; INSULIN ASPART; INSULIN, ASP(B28)-;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; BLOOD; METABOLISM; METHODOLOGY; PATHOLOGY; REVIEW;

ADULT; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; IMMUNOASSAY; INSULIN; MALE;

EID: 65849155958     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.8.1006     Document Type: Article

References (15)

1. Heald AH, Bhattacharya B, Cooper H, Ullah A, et al. Most commercial insulin assays fail to detect recombinant insulin analogues. Ann Clin Biochem. 2006;43:306-308.
2. Owen WE, Roberts, WL. Cross-reactivity of three recom binant insulin analogs with five commercial insulin immunoassays. Clin Chem. 2004;50:257-259.
3. Moriyama M, Hayashi N, Ohyabu C, Mukai M, Kawano S, Kumagai S. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay. Clin Chem. 2006;52:1423-1426.
4. Agin A, Jeandidier N, Gasser F, Grucker D, Sapin R. Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay. Diabetes Metab. 2007;33: 205-212.
5. Agin A, Jeandidier N, Gasser F, Grucker D, Sapin R. Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: bi-insulin IRMA preliminary assessment. Clin Chem Lab Med. 2006;44:1379-1382.
6. Nerby CL, Stickle DF. Evaluation of cross-reactivity of the insulin analog glulisine (Apidra) with the DPC Immulite insulin assay. Presented at the American Society for Clinical Pathology Annual Meeting; October 18-21, 2007; New Orleans, Louisiana.
7. Song D, Davidson J. Cross-reactivity of Actrapid and three insulin analogues in the Abbott IMx insulin immunoassay. Ann Clin Biochem. 2007;44:197-198.
8. Birkinshaw VJ, Gurd MR, Randall SS, Curry AS, Price DE, Wright PH. Investigations in a case of murder by insulin poisoning. Br Med J. 1958;2:463-468.
9. Gill GV. The spectrum of brittle diabetes. J R Soc Med. 1992;85:259-261.
10. Jezequel C, de Kerdanet M, Girre MA. Hypoglycemia provoked by clandestine injections of insulin in the diabetic child [article in French]. Ann Pediatr (Paris). 1993;40: 32-36.
11. Grunberger G, Weiner JL, Silverman R, Taylor S, Gorden P. Factitious hypoglycemia due to surreptitious administration of insulin: diagnosis, treatment, and long-term follow-up. Ann Intern Med. 1988;108:252-257.
12. Marks V, Teale JD. Hypoglycemia: Factitious and felonious. Endocrinol Metab Clin North Am. 1999;28:579-601.
13. Trenque T, Hoizey G, Lamiable D. Serious hypoglycemia: Munchausen's syndrome? Diabetes Care. 2001;24: 792-793.
14. Charlton R, Smith G, Day A. Munchausen's syndrome manifesting as factitious hypoglycaemia. Diabetologia. 2001;44:784-785.
15. Hirshberg B, Skarulis MC, Pucino F, Csako G, Brennan R, Gorden P. Repaglinide-induced factitious hypoglycemia. J Clin Endocrinol Metab. 2000;86:475-477.